SPIE Photonics West 2024 Opens for Registration
Registration has opened for SPIE Photonics West 2024, which will run from 27 January to 1 February at the Moscone Center in San Francisco. The largest annual conference and exhibition in optics and photonics, the week will include more than 4,500 technical presentations as well as showcasing over 1,200 companies in three focused exhibitions. Photonics West brings together researchers, innovators, engineers, and business leaders from across the globe for an engaging week of research sharing, collaboration forming, and innovation-inspiring exchanges.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231005492002/en/
Attendees at SPIE Photonics West 2023 (Photo: Business Wire)
SPIE Photonics West has four major application areas emphasizing the latest technologies and discoveries that utilize optics and photonics. BiOS highlights new research in biophotonics, biomedical optics, and imaging for diagnostics and therapeutics; LASE focuses on the laser industry and its diverse applications; OPTO covers optoelectronics, photonic materials, and optical devices; and, now in its third year, Quantum West features quantum 2.0 technologies from quantum sensing and information systems to quantum enabled materials and devices and quantum biology. This year, Quantum West will also include a Quantum West Business Summit highlighting the work of moving quantum technologies to market.
Featuring more than 1,200 companies with product launches, live demonstrations, and cutting-edge technologies on display, the accompanying exhibitions during Photonics West provide terrific platforms for the diverse and healthy photonics industry.
“The demand for exhibition space at Photonics West is always a great indicator of the health of our industry, and this year, we've responded to increased demand by expanding the footprint 15% over last year’s and expect to sell out once again,” said SPIE Global Exhibition Services Director Bonnie Peterson. “We’re excited to welcome returning and new companies and look forward to offering our exhibitor community an engaging platform for their technologies, applications, and market-ready systems and components.”
New this year, the Quantum West Expo, 30-31 January, will showcase worldwide providers of the latest quantum technologies. The BiOS Expo — featuring new and transformative technologies in biomedical optics and healthcare applications — runs 27-28 January, while the Photonics West Exhibition, 30 January to 1 February, encompasses the latest from laser manufacturers and suppliers as well as other innovative optics and photonics devices, components, systems, and services. In addition, the dynamic industry program also returns with a renewed focus on the markets and applications shaping the photonics industry. All three exhibitions and the industry program are free to attend with a SPIE Photonics West registration.
The vibrant, event-packed week will cover the latest technologies and industry developments across the optics and photonics spectrum, from the SPIE BiOS Hot Topics and conference plenary sessions to the Prism Awards and the SPIE Startup Challenge. Highlighting the latest innovative research breakthroughs are the dynamic Hot Topics and plenary speakers, including Lingyan Shi, University of California, San Diego; Giuliano Scarcelli, University of Maryland; Paul Beard, University College London; Ben Vakoc, Wellman Center for Photomedicine, Massachusetts General Hospital, and Harvard Medical School; Philip Tinnefeld, LMU-Munich; Charles Lin, Massachusetts General Hospital Center for Systems Biology; Ryan Field, Kernel; Michelle Digman, University of California, Irvine; Jun Ye, JILA; Stephanie Simmons, Photonic, Inc; Marlan Scully, Texas A&M; Paul Prucnal, Princeton University; Åsa Haglund, Chalmers; Roel Baets, Ghent University/imec; Ahmed Diallo, ARPA-E; Akira Furusawa, University of Tokyo and RIKEN; Laura Na Liu, University of Stuttgart; Siddharth Ramachandran, Boston University; Bruce Tromberg, National Institutes of Health; R. Rox Anderson, Wellman Center for Photomedicine, Massachusetts General Hospital, and Harvard Medical School; Griff Harsh, University of California, Davis; Mary Lou Jepsen, Openwater; Cynthia Toth, Duke University; and Eric Henderson, Dartmouth-Hitchcock Medical Center.
Alongside the conferences and exhibitions, Photonics West will also offer 57 technical courses, including the popular Quantum Computing: A Concise Introduction, as well as eight new courses on topics such as inverse design for photonics, trends in miniature camera technology, photoacoustic imaging, and optical design for AR/VR/MR technologies.
The wide-ranging educational program complements numerous professional development workshops, a comprehensive job fair, and valuable networking opportunities for technical attendees, SPIE Members, and exhibitors.
Full conference registration for Photonics West includes access to the three-day SPIE AR | VR | MR event, which focuses on augmented, virtual, and mixed reality and the vital role that optics and photonics play in hardware and headset development. This popular program incorporates more than 30 invited industry talks, keynotes, and panels with speakers representing a range of exciting companies, including META, Oppo, XREAL, and Magic Leap; a two-day exhibition; and a headset museum featuring more than 100 headsets from the late 1980s to the present day.
This year, SPIE will also introduce its inaugural Global Business Forum. This one-day informational and networking opportunity held on 29 January, with a focus on current and emerging trends across the international optics and photonics industry and markets, will include insights from Tematys’ Thierry Robin, Yole Group’s Jean-Christophe Eloy, BOS Photonics’ Bo Gu; and Harlin’s John Lincoln, among others. Registration for the Global Business Forum is separate from Photonics West and will be available via the event website.
“Photonics West 2024 promises to be an engaging and thought-provoking week of networking and learning opportunities,” said SPIE Senior Director of Technical Programs Marilyn Gorsuch. “We are particularly excited to be expanding our Quantum West programming, including the addition of a quantum-focused exhibit. As the first major community gathering of the year, we continue to bring together a unique nexus of industry leaders and highly regarded researchers whose collaborations drive products, innovation, and technical breakthroughs. We expect an increase from last year’s 22,000 registered attendees and invite you to join the global photonics community and experience all that Photonics West 2024 has to offer.”
For more information and to register, please visit https://spie.org/pw.
About SPIE
SPIE, the international society for optics and photonics, brings engineers, scientists, students, and business professionals together to advance light-based science and technology. The Society, founded in 1955, connects and engages with our global constituency through industry-leading conferences and exhibitions; publications of conference proceedings, books, and journals in the SPIE Digital Library; and career-building opportunities. Over the past five years, SPIE has contributed more than $22 million to the international optics community through our advocacy and support, including scholarships, educational resources, travel grants, endowed gifts, and public-policy development. www.spie.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231005492002/en/
Contact information
Daneet Steffens
Public Relations Manager
daneets@spie.org
+1 360 685 5478
@SPIEtweets
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Fujirebio Receives Marketing Clearance for Lumipulse ® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-vitro Diagnostic Test as an Aid to Identify Patients With Amyloid Pathology Associated With Alzheimer’s Disease17.5.2025 09:58:00 EEST | Press release
Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio in-vitro diagnostic (IVD) test for the assessment of amyloid pathology in patients being evaluated for Alzheimer’s disease and other causes of cognitive decline. The test, which was granted Breakthrough Device Designation by the FDA, is the first FDA cleared blood-based IVD test in the U.S. to aid to identify patients with amyloid pathology associated with Alzheimer’s Disease (AD). Alzheimer’s disease currently affects an estimated 7.2 million Americans, a number projected to rise to nearly 14 million by 2060.1 It is a leading cause of disability and death. AD develops over many years, long before symptoms are evident, but the lack of accessible, minimally invasive diagnostics results in many patients remaining undiagnosed until the disease is well advanced, when few effective interventions remain. The Lumipulse G pT
IFF Announces Pricing of Tender Offers For Certain Outstanding Series of Notes17.5.2025 00:17:00 EEST | Press release
IFF (NYSE: IFF) announced today the Total Consideration (as defined below) payable in connection with its previously announced tender offers to purchase for cash: (i) up to $1,100,000,000 aggregate purchase price, excluding accrued and unpaid interest (the “Amended Pool 1 Maximum Amount”), of its 1.230% Senior Notes due 2025 (the “2025 Notes”), 1.832% Senior Notes due 2027 (the “2027 Notes”), 4.450% Senior Notes due 2028 (the “2028 Notes”) and 2.300% Senior Notes due 2030 (the “2030 Notes” and collectively with the 2025 Notes, the 2027 Notes and the 2028 Notes, the “Pool 1 Notes”) and (ii) up to $900,000,000 aggregate purchase price, excluding accrued and unpaid interest (the “Amended Pool 2 Maximum Amount” and, together with the Amended Pool 1 Maximum Amount, the “Amended Maximum Amounts”), of its 3.268% Senior Notes due 2040 (the “2040 Notes”), 4.375% Senior Notes due 2047 (the “2047 Notes”), 5.000% Senior Notes due 2048 (the “2048 Notes”) and 3.468% Senior Notes due 2050 (the “2050
Origins Launches in the U.S. Amazon Premium Beauty Store16.5.2025 16:00:00 EEST | Press release
Origins, with over 30 years of expertise in combining naturally-derived and scientifically crafted ingredients for powerful skincare, announced its official debut in the U.S. Amazon Premium Beauty store today. Origins will offer its iconic skincare and body care products along with giftable sets that are perfect for any occasion. Origins will now bring naturally-derived, effective beauty to Amazon customers nationwide with convenience and thoughtful gifting in mind. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250516435958/en/ This launch marks a strategic step in Origins’ ongoing efforts to meet the evolving needs of skincare shoppers, seeking high-performance, conscious beauty on their favorite platforms. By expanding to the U.S. Amazon Premium Beauty store, Origins reinforces its commitment to delivering both efficacy and accessibility to even more consumers. Amazon customers will now be able to discover and purchase Or
The smarter E Europe 2025: Studies, Technologies and Market Trends for the Energy System of Tomorrow16.5.2025 13:47:00 EEST | Press release
Exactly one week has passed since The smarter E Europe closed its doors in Munich. Once again, Europe’s largest alliance of exhibitions for the energy industry turned the Bavarian capital into the epicenter of the global energy sector and impressed with outstanding results. Over the course of three days, 2,737 exhibitors from 57 countries showcased their technologies, business models and market-ready solutions for an intelligent, interconnected and fully renewable energy system. Around 107,000 professionals from 157 nations took the opportunity to connect, initiate partnerships and launch new projects. The accompanying conferences and side events also attracted strong interest, drawing more than 2,600 participants. The message sent out by The smarter E Europe and its four exhibitions – Intersolar Europe, ees Europe, Power2Drive Europe and EM-Power Europe – was clear: We are the energy system. This press release features multimedia. View the full release here: https://www.businesswire.c
IFF Announces Early Tender Results and Increase of Tender Offers for Certain Outstanding Series of Notes16.5.2025 13:30:00 EEST | Press release
IFF (NYSE: IFF) announced today the early tender results for its tender offers to purchase for cash certain of its outstanding series of Notes. IFF also announced it has increased the previously announced Pool 1 Maximum Amount (as defined below) from $1,000,000,000 to $1,100,000,000 (the “Amended Pool 1 Maximum Amount”), the Pool 2 Maximum Amount (as defined below) from $800,000,000 to $900,000,000 (the “Amended Pool 2 Maximum Amount”, and together with the Amended Pool 1 Maximum Amount, the “Amended Maximum Amounts”), the 2027 Series Tender Cap (as defined below) from $300,000,000 to $400,000,000 and the 2050 Series Tender Cap (as defined below) from $600,000,000 to $649,114,000. The 2025 Notes Series Tender Cap and the 2040 Notes Series Tender Cap (each as defined below) remain unchanged at $500,000,000 and $450,000,000, respectively. Details of tender offers IFF initially offered to purchase for cash: (i) up to $1,000,000,000 aggregate purchase price, excluding accrued and unpaid in
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom